Daytime Rest
Daytime rest refers to periods of reduced activity, wakeful relaxation, or sleep taken during the day, distinct from the primary nocturnal sleep period. It encompasses various forms, from brief power naps to longer siestas, and is a common human behavior observed across cultures and throughout history. The practice of resting during the day is influenced by both biological imperatives and social factors.
Biological Basis
The biological basis of daytime rest is rooted in the interplay of the circadian rhythm and homeostatic sleep drive. The circadian rhythm dictates daily cycles of alertness and sleepiness, often leading to a natural dip in alertness in the mid-afternoon, even after adequate nocturnal sleep. The homeostatic sleep drive, on the other hand, builds up throughout wakefulness, increasing the physiological need for sleep. Daytime rest, particularly napping, can temporarily reduce this homeostatic pressure, leading to improved alertness and performance. Research suggests that even short periods of daytime rest can facilitate memory consolidation, enhance cognitive functions such as attention and problem-solving, and aid in emotional regulation by reducing stress hormones.
Clinical Relevance
The clinical relevance of daytime rest is multifaceted. For healthy individuals, strategic napping can boost productivity, creativity, and overall well-being. It can be particularly beneficial for individuals with disrupted sleep schedules, such as shift workers, helping to mitigate the negative impacts of sleep deprivation. However, excessive or poorly timed daytime rest can sometimes interfere with nocturnal sleep, potentially exacerbating insomnia or other sleep disorders. In some cases, a frequent or strong need for daytime rest may also be a symptom of underlying health conditions, including sleep disorders like narcolepsy or sleep apnea, or other medical conditions.
Social Importance
Daytime rest holds significant social importance, influencing workplace policies, cultural practices, and public health initiatives. In many cultures, the siesta is an ingrained tradition, providing a midday break that supports physical and mental recuperation. In modern industrial societies, the recognition of sleep's impact on performance and safety has led to discussions about incorporating designated rest periods or nap rooms in workplaces, especially in professions requiring high vigilance (e.g., pilots, medical professionals, long-haul drivers). Promoting healthy daytime rest practices can contribute to public safety, reduce the economic burden of sleep-related accidents, and improve the overall quality of life.
Methodological and Statistical Considerations
Even with the use of meta-analysis across multiple cohorts, the identification of genetic variants with small effect sizes, characteristic of complex traits such as daytime rest, remains a significant challenge. While robust replication efforts are essential for confirming initial findings, the absence of replication for specific associations or the failure to confirm them in independent cohorts can lead to an overestimation of effect sizes from discovery phases, thereby affecting the reliability of the overall conclusions. [1] The meta-analytic approach, while powerful for increasing statistical power, is also susceptible to heterogeneity among included studies, which can arise from differences in study design, population characteristics, or the specific methods used to assess daytime rest. Although measures are typically taken to assess and account for this heterogeneity, such as fixed-effects inverse-variance averaging, unexplained variability across studies can obscure true genetic associations or result in imprecise estimates of genetic effects, limiting the overall confidence in combined results. [2]
Phenotypic Definition and Measurement Variability
A notable limitation in the genetic study of daytime rest stems from the inherent variability in how this phenotype is defined and measured across different research contexts. Studies may utilize a range of assessment methods, from self-reported questionnaires to more objective techniques like actigraphy or polysomnography, each possessing distinct levels of accuracy and precision. This heterogeneity in measurement scales and approaches, akin to using different units for the same underlying characteristic, introduces considerable noise into the data, which can complicate meta-analyses and impede the consistent identification of genetic signals. [1] Furthermore, specific biases within individual study cohorts, potentially influenced by unique selection criteria or demographic compositions, could inadvertently affect the observed patterns or prevalence of daytime rest. These cohort-specific nuances may not always be fully mitigated by statistical adjustments, posing a risk of generating spurious associations or masking genuine genetic effects that are broadly consistent across populations.
Generalizability and Environmental Context
The applicability of genetic findings related to daytime rest is significantly restricted by the ancestral composition of the study populations. If discovery and replication cohorts primarily comprise individuals from a specific ancestry, as is often the case in large-scale genetic studies, the identified genetic associations may not be directly extensible or relevant to populations of diverse ancestral backgrounds. This limitation underscores the critical need for more inclusively diverse cohorts to ensure that genetic insights into daytime rest are broadly applicable across the global population. [1], [3] Moreover, the complex interplay between genetic predispositions and environmental exposures represents a substantial, yet often underexplored, aspect of daytime rest. Environmental factors such as lifestyle, occupational demands, psychological stress, and even local light-dark cycles can profoundly influence individual resting patterns and may interact with genetic factors in intricate ways. The current understanding often lacks comprehensive data on these gene-environment interactions, contributing to the "missing heritability" of the trait, where a significant portion of its variability remains unexplained by commonly studied genetic variants alone. [3]
Variants
Genetic variants play a crucial role in influencing an individual's physiology, including the complex regulation of sleep and the propensity for daytime rest. Single nucleotide polymorphisms (SNPs) within or near genes involved in metabolic regulation, neuronal signaling, and cellular processes can subtly alter gene function, thereby contributing to individual differences in sleep patterns and the body's need for recovery. [4] These variants collectively highlight the intricate genetic architecture underlying the body's energy balance and neurological functions, which are critical for maintaining optimal wakefulness and recognizing the need for rest. [4]
Several variants are associated with genes critical for energy homeostasis and neurological function. The variant rs11615756 in the _KSR2_ (Kinase Suppressor of Ras 2) gene is of interest because _KSR2_ is known to play a role in energy metabolism, insulin signaling, and appetite regulation. Alterations in these pathways, potentially influenced by this variant, can affect overall energy balance and consequently impact the body's demand for rest and recovery. [4] Similarly, variants rs2653349 and rs2653344 are located within the _HCRTR2_ (Hypocretin (Orexin) Receptor 2) gene, which is fundamental to regulating the sleep-wake cycle and promoting wakefulness. Variations in _HCRTR2_ can influence the stability of wakefulness and the propensity for daytime sleepiness, directly impacting the need for and quality of daytime rest. [4]
Other variants are found in regions associated with RNA processing, gene regulation, and cellular structure. The variant rs385199, located in the vicinity of _RPS26P8_ (Ribosomal Protein S26 Pseudogene 8) and _LINC02210_ (Long Intergenic Non-Coding RNA 2210), may influence gene expression and ribosomal function, which are vital for protein synthesis and cellular repair during periods of rest. [4] Variants such as rs2431108 near _NIHCOLE_ and _RNU6-334P_ (RNA, U6 Small Nuclear 334 Pseudogene) could affect small RNA function, thereby modulating broader gene regulatory networks that impact cellular responses to stress and fatigue. [4] Furthermore, rs2861805, located between _RPL12P40_ (Ribosomal Protein L12 Pseudogene 40) and _RN7SKP182_ (RNA, 7SK Small Nuclear Pseudogene 182), may also contribute to altered gene expression or RNA processing, influencing the physiological need for restorative daytime rest.
Variants impacting cell signaling, development, and tight junction function also contribute to the genetic landscape of daytime rest. The variants rs9965170 and rs2048524 near _SKOR2_ (SKI Family Transcriptional Regulator 2) and _MIR4527HG_ (MIR4527 Host Gene) may affect transcriptional regulation, potentially influencing neuronal development or function that can impact the quality and duration of rest. [4] Variants rs13284688 and rs34799682 in the region of _KRT18P24_ (Keratin 18 Pseudogene 24) and _CHCHD2P9_ (Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 2 Pseudogene 9) might be involved in cellular structure or mitochondrial function, which are directly relevant to energy production and cellular recovery processes during rest. [4] The variant rs12140153 in _PATJ_ (PALS1 Associated Tight Junction Protein), a gene involved in cell polarity and tight junctions, could affect barrier functions in the brain or cell-to-cell communication, impacting neurological health and the regulation of rest. Lastly, rs2250377 in _SHISA4_, which modulates AMPA receptor function, and rs10875622 in _STK32A_ (Serine/Threonine Kinase 32A), a kinase gene, may influence synaptic plasticity, neuronal excitability, and stress responses, all of which are critical factors in the regulation of sleep architecture and the body's demand for daytime rest.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs11615756 | KSR2 | daytime rest measurement |
| rs385199 | RPS26P8 - LINC02210 | daytime rest measurement total cortical area measurement |
| rs2431108 | NIHCOLE - RNU6-334P | anxiety, stress-related disorder, major depressive disorder daytime rest measurement Postural instability smoking initiation insomnia |
| rs2653349 rs2653344 |
HCRTR2 | circadian rhythm daytime rest measurement chronotype measurement |
| rs9965170 rs2048524 |
SKOR2 - MIR4527HG | body mass index daytime rest measurement metabolic syndrome educational attainment |
| rs13284688 rs34799682 |
KRT18P24 - CHCHD2P9 | daytime rest measurement |
| rs12140153 | PATJ | circadian rhythm excessive daytime sleepiness measurement circadian rhythm, excessive daytime sleepiness measurement, sleep duration trait, insomnia measurement body mass index waist-hip ratio |
| rs2250377 | SHISA4 | daytime rest measurement body mass index |
| rs2861805 | RPL12P40 - RN7SKP182 | daytime rest measurement |
| rs10875622 | STK32A | daytime rest measurement |
Defining the State of Rest and Its Operationalization
The concept of 'rest' in physiological assessments is fundamentally an operational definition, delineating a baseline state crucial for evaluating dynamic biological responses. This state is characterized by the absence of strenuous physical activity, serving as a critical reference point for assessing an individual's inherent physiological status. [5] In research settings, particularly within studies involving exercise physiology, measurements taken "at rest" are precisely defined as those collected prior to the initiation of activities such as exercise treadmill testing (ETT). [5] This standardized approach ensures that baseline physiological data are consistent and provide a stable internal environment against which changes induced by physical exertion or other stimuli can be accurately measured.
Physiological Parameters and Their Measurement at Rest
During the defined state of rest, several key physiological parameters are routinely measured, which include systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate. [5] These "at rest" values are integral for a comprehensive cardiovascular assessment and are frequently utilized as covariates in multivariable models to adjust for an individual's baseline physiological status. [5] For example, baseline heart rate is a standard covariate for ETT phenotypes, and resting systolic and diastolic blood pressures are specifically adjusted for when evaluating exercise and recovery blood pressure responses. [5] The precise measurement of these parameters at rest is therefore essential for accurately interpreting subsequent physiological changes and understanding their clinical significance.
Clinical and Research Significance of Resting Measurements
Measurements obtained during a state of rest hold substantial clinical and research importance, primarily serving as indispensable covariates and baseline indicators in the study of various health traits. They are critical for adjusting for individual physiological variations when analyzing more complex phenotypes, such as those derived from echocardiography, brachial artery endothelial function, and treadmill exercise responses. [5] By meticulously accounting for resting values, researchers can more effectively isolate the effects of specific interventions, environmental factors, or genetic influences on dynamic physiological traits, thereby enhancing the accuracy and interpretability of study findings. This precise adjustment for baseline resting parameters is vital for identifying true associations with outcomes like cardiovascular disease risk and other metabolic indicators. [5]
Biological Background of Daytime Rest
Daytime rest, encompassing periods of reduced physical and mental activity, is a crucial physiological state integral to maintaining overall health and systemic homeostasis. While not always involving sleep, these periods allow for various biological processes that facilitate recovery, energy conservation, and cellular repair. The underlying mechanisms involve intricate molecular pathways, genetic regulation, and coordinated tissue-level responses that adapt the body to a state of lower demand, preparing it for subsequent activity.
Metabolic Regulation and Energy Homeostasis
During periods of daytime rest, the body prioritizes metabolic processes aimed at energy conservation and replenishment of reserves. Genetic variations play a significant role in individual metabolic profiles, with genome-wide association studies identifying numerous loci influencing metabolite concentrations in human serum, providing insights into affected pathways. [6] For instance, lipid metabolism is a key area of regulation, with genes like HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) influencing LDL-cholesterol levels, partly through mechanisms like alternative splicing of its exon 13. [7] Other genes, such as ANGPTL3 and ANGPTL4, are known to regulate lipid metabolism, and variants in these genes can affect triglyceride and HDL levels. [8] Fatty acid metabolism, including the function of enzymes like medium-chain acyl-CoA dehydrogenase encoded by ACADM, is also critical, with genetic variations in this pathway potentially moderating cognitive outcomes and influencing biochemical phenotypes. [9] Beyond lipids, genes like GLUT9 are associated with serum uric acid levels, highlighting the genetic influence on metabolic waste product management and kidney function, which are also relevant during rest. [10]
Hormonal and Signaling Pathway Modulation
Daytime rest is deeply intertwined with the modulation of hormonal and cellular signaling pathways that govern body-wide physiological adjustments. Endocrine-related traits, including levels of thyroid-stimulating hormone (TSH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and dehydroepiandrosterone sulfate (DHEAS), are influenced by genetic factors and signify the systemic hormonal environment during states of rest and activity. [11] The metabolism of thyroid hormones, such as thyroxine (T4) and tri-iodothyronine (T3), is also crucial for metabolic rate regulation and overall energy balance, with studies examining the impact of partial substitution therapies. [12] At the cellular level, signaling cascades like the mitogen-activated protein kinase (MAPK) pathway are involved in responses to physiological changes, including those induced by exercise, and are controlled by proteins like tribbles. [5] Local mediators such as prostaglandins and lipoxygenase-derived fatty acid metabolites also play roles in diverse cellular functions, potentially influencing inflammatory responses and tissue repair during rest. [13]
Cardiovascular and Musculoskeletal System Dynamics
The cardiovascular and musculoskeletal systems undergo critical restorative processes during daytime rest, facilitated by specific molecular and tissue-level interactions. Cardiac morphogenesis and function are significantly regulated by genes such as MEF2C, which also influences extracellular matrix remodeling, ion handling, and cardiomyocyte metabolism. [5] The MAPK1 gene, involved in MAPK signaling, mediates skeletal muscle responses, indicating its role in muscle recovery and adaptation during periods of rest following activity. [5] Furthermore, vascular function, including brachial artery endothelial function and ventricular remodeling, involves genes like NRG2 (neuregulin-2), a member of the epidermal growth factor family that binds to ErbB receptors. [5] Angiotensin II can also impact vascular smooth muscle cells by increasing the expression of phosphodiesterase 5A (PDE5A), which modulates cGMP signaling, highlighting a mechanism for blood pressure and vascular tone regulation that is relevant to cardiovascular recovery during rest. [5]
Genetic Predisposition and Homeostatic Disruptions
Genetic mechanisms underpin individual variations in the capacity for effective rest and susceptibility to conditions that disrupt it. Genome-wide association studies have identified common variants in several genomic regions associated with restless legs syndrome, a neurological disorder characterized by an irresistible urge to move the legs, particularly during rest, thereby directly impacting the ability to achieve a restorative state. [14] Beyond specific disorders, genetic variations influence homeostatic processes at a fundamental level. For example, protein quantitative trait loci (pQTLs) reveal genetic effects on protein levels, including those of SHBG and TNF-alpha, which are implicated in hormone transport and inflammatory responses, respectively, both crucial for maintaining physiological balance during rest. [12] Genes involved in iron metabolism, such as TF (transferrin) and HFE, also contribute significantly to variations in serum transferrin levels, affecting oxygen transport and cellular energy processes that are modulated during periods of reduced activity. [4]
Metabolic Regulation and Energy Homeostasis
The body's metabolic state, including during periods of rest, is intricately linked to lipid metabolism, which involves the synthesis, transport, and breakdown of fats. Genetic variations at numerous loci contribute to polygenic dyslipidemia, impacting levels of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides. [15] For instance, ANGPTL3 and ANGPTL4 are key regulators, with ANGPTL3 affecting overall lipid metabolism and ANGPTL4 variations influencing triglyceride levels, demonstrating how specific genetic changes can modulate lipid homeostasis. [8] Sterol regulatory element-binding protein 2 (SREBP-2) also plays a role in cholesterol biosynthesis and can link isoprenoid metabolism with adenosylcobalamin metabolism. [8] Such intricate regulation ensures appropriate energy substrate availability and storage, critical for maintaining physiological balance even during inactive periods.
Beyond lipids, glucose and uric acid metabolism are fundamental to cellular energy and waste management. The GLUT9 gene, also known as SLC2A9, is a crucial facilitative glucose transporter family member associated with serum uric acid levels and renal urate transport. [10] Dysregulation of SLC2A9 can lead to altered uric acid concentrations, with pronounced sex-specific effects, underscoring its role in metabolic health. [6] Furthermore, genes like G6PC2-ABCB1 and MTNR1B influence glucose levels and insulin secretion, while PANK1 encodes panthothenate kinase, an enzyme vital for coenzyme A synthesis, demonstrating interconnectedness within metabolic pathways that impact overall physiological state. [16]
Cellular Signaling and Gene Expression Control
Cellular functions, including those during periods of rest, are orchestrated by complex signaling cascades that involve receptor activation and subsequent intracellular signal transduction. The mitogen-activated protein kinase (MAPK) pathway, for example, is a critical signaling cascade involved in various cellular processes, and its activation is influenced by factors like age and acute exercise . Cyclic AMP (cAMP)-dependent chloride transport, mediated by channels like CFTR, represents another crucial signaling mechanism that can be altered in smooth muscle cells, impacting cellular mechanics and ion homeostasis . Angiotensin II can also influence cGMP signaling by increasing the expression of phosphodiesterase 5A (PDE5A) in vascular smooth muscle cells, illustrating intricate feedback loops that modulate cell responses .
Regulation of gene expression and protein function are paramount for maintaining cellular integrity and adapting to physiological demands. Transcription factor regulation, such as that involving SREBP-2 in lipid metabolism, directly controls gene expression to modulate metabolic pathways. [8] Protein modification, including post-translational events, further refines protein activity; for instance, PJA1 encodes a RING-H2 finger ubiquitin ligase, highlighting the role of ubiquitination in protein degradation and regulation. [10] The identification of protein quantitative trait loci (pQTLs) demonstrates that genetic variants can influence protein levels, thereby impacting downstream cellular functions and providing insights into the genetic architecture of protein regulation. [12]
Interconnected Physiological Networks
Physiological states, including periods of daytime rest, are not governed by isolated pathways but by a highly interconnected network of molecular interactions. Pathway crosstalk allows different signaling and metabolic routes to influence one another, creating a robust and adaptable system. For example, the interplay between lipid and glucose metabolism, where genetic variants in one system can impact the other, demonstrates this complex network interaction. [6] The comprehensive measurement of endogenous metabolites through metabolomics provides a functional readout of the physiological state, revealing how genetic variants can alter the homeostasis of key lipids, carbohydrates, or amino acids across these interconnected networks. [6]
The hierarchical regulation within these networks ensures coordinated responses to internal and external cues. From gene expression to protein function and metabolic flux, multiple layers of control operate to maintain homeostasis. The collective activity and interactions of numerous individual pathways give rise to emergent properties, which are the complex physiological outcomes observed at the organismal level, such as the overall metabolic profile or cardiovascular function . Understanding these systems-level integrations is crucial for comprehending how genetic predispositions or environmental factors can subtly shift the balance of these networks, influencing health and disease.
Dysregulation and Disease Pathways
Dysregulation within these intricate pathways can lead to various pathological conditions that impact overall health and well-being. For instance, common genetic variants contributing to polygenic dyslipidemia highlight how deviations from normal lipid metabolism can predispose individuals to cardiovascular diseases. [15] Similarly, alterations in uric acid transport mediated by SLC2A9 are linked to conditions like gout, demonstrating how a single gene's dysregulation can have significant clinical consequences. [17] The body often employs compensatory mechanisms to counteract such dysregulations, but sustained imbalances can overwhelm these systems, leading to chronic disease states.
Identifying the specific molecular components and pathways involved in disease states offers promising avenues for therapeutic intervention. Genome-wide association studies (GWAS) have been instrumental in pinpointing common genetic variants associated with traits like type 2 diabetes and triglyceride levels, revealing potential drug targets. [18] For example, variants in MTNR1B affecting insulin secretion or PANK1 involved in coenzyme A synthesis could represent targets for metabolic disorders. [16] By elucidating the genetic architecture of these pathways and their dysregulation, researchers can develop more precise and effective strategies to restore physiological balance and improve health outcomes.
Clinical Relevance of Daytime Rest
The physiological state of 'daytime rest' serves as a crucial baseline for assessing an individual's cardiovascular health and overall systemic function. While not a disease entity itself, the parameters measured during periods of rest provide fundamental insights into an individual's baseline physiological status, which is vital for diagnosis, prognosis, and personalized patient management. The interpretation of dynamic physiological responses, such as those elicited during exercise, heavily relies on accurately established resting values.
Baseline Cardiovascular Assessment and Prognostic Indicators
The physiological parameters observed during a state of 'daytime rest'—specifically resting systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR)—are fundamental in clinical assessment. These baseline measurements are crucial for interpreting dynamic physiological responses, such as those observed during treadmill exercise tests, where they serve as critical covariates for exercise and recovery parameters. [5] Deviations from normal resting values can serve as early indicators of underlying cardiovascular dysfunction, even before overt symptoms manifest, thereby offering diagnostic utility.
The prognostic value of these resting parameters is significant, as persistently elevated resting SBP, DBP, or HR are well-established predictors of long-term cardiovascular outcomes. For instance, high resting blood pressure is a known risk factor for the progression of conditions like subclinical atherosclerosis [19] and can influence the trajectory of disease progression. Monitoring these parameters during periods of rest provides insights into an individual's baseline cardiovascular load and potential for future adverse events, aiding in the prediction of disease onset and severity.
Risk Stratification and Personalized Management
Assessing an individual's cardiovascular profile during 'daytime rest' is integral to effective risk stratification. Clinicians utilize resting blood pressure and heart rate measurements to identify individuals at higher risk for cardiovascular diseases, guiding the implementation of targeted prevention strategies. [19] This includes identifying those who may benefit most from lifestyle modifications, such as dietary changes or increased physical activity, or from early pharmacological interventions to mitigate future health complications.
The insights gained from resting physiological data support personalized medicine approaches. By understanding an individual's unique resting cardiovascular profile, clinicians can tailor treatment selection and monitoring strategies. For example, the effectiveness of anti-hypertensive or heart rate-modulating medications can be closely monitored by observing changes in resting SBP, DBP, and HR over time, allowing for adjustments to optimize patient care and treatment response. [5] Such personalized adjustments enhance the precision of therapeutic interventions and improve patient outcomes.
Interplay with Comorbidities and Therapeutic Monitoring
The state of 'daytime rest' allows for the observation of physiological parameters that are often associated with a spectrum of comorbidities. Elevated resting blood pressure, for instance, frequently co-occurs with metabolic disorders like diabetes and dyslipidemia [19] and is a key component of the metabolic syndrome. Similarly, an abnormal resting heart rate can be indicative of broader systemic issues or contribute to the complexity of existing conditions, highlighting overlapping phenotypes that require integrated management.
Continuous monitoring of resting cardiovascular parameters is a practical and non-invasive strategy for managing these associated conditions and evaluating treatment efficacy. For patients with known comorbidities, tracking resting SBP, DBP, and HR helps assess the overall impact of disease and treatment on cardiovascular load. This enables clinicians to make informed decisions regarding therapeutic adjustments, thereby improving patient care and potentially mitigating complications related to overlapping phenotypes. [5]
References
[1] Fornage, M et al. "Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium." Ann Neurol, 2011.
[2] Yuan, X et al. "Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes." Am J Hum Genet, 2008.
[3] Newman, AB et al. "A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium." J Gerontol A Biol Sci Med Sci, 2010.
[4] Benyamin, B. et al. "Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels." Am J Hum Genet, vol. 84, no. 1, 2009, pp. 60–65.
[5] Vasan, R.S., et al. "Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study." BMC Med Genet, vol. 8 Suppl 1, 2007, p. S2.
[6] Gieger, C. et al. "Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum." PLoS Genet, vol. 4, no. 11, 2008, e1000282.
[7] Burkhardt, R. et al. "Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13." Arterioscler Thromb Vasc Biol, 2009.
[8] Willer, C.J., et al. "Newly identified loci that influence lipid concentrations and risk of coronary artery disease." Nat Genet, vol. 40, no. 2, 2008, pp. 161-69.
[9] Caspi, A. et al. "Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism." Proc Natl Acad Sci U S A, vol. 104, 2007, pp. 18860–18865.
[10] Li, S. et al. "The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts." PLoS Genet, vol. 3, no. 11, 2007, e194.
[11] Hwang, SJ. et al. "A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study." BMC Med Genet, vol. 8, suppl. 1, 2007, S10.
[12] Melzer, D. et al. "A genome-wide association study identifies protein quantitative trait loci (pQTLs)." PLoS Genet, vol. 4, no. 5, 2008, e1000072.
[13] Unterwurzacher, I. et al. "Rapid sample preparation and simultaneous quantitation of free prostaglandins and lipoxygenase derived fatty acid metabolites by LC-MS/MS from small." J Chromatogr B Analyt Technol Biomed Life Sci, 2008.
[14] Winkelmann, J. et al. "Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions." Nat Genet, vol. 39, no. 8, 2007, pp. 1000–1006.
[15] Kathiresan, S. et al. "Common variants at 30 loci contribute to polygenic dyslipidemia." Nat Genet, vol. 40, no. 12, 2008, pp. 1417-1424.
[16] Sabatti, C., et al. "Genome-wide association analysis of metabolic traits in a birth cohort from a founder population." Nat Genet, vol. 41, no. 1, 2009, pp. 35-46.
[17] Vitart, V., et al. "SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout." Nat Genet, vol. 40, no. 4, 2008, pp. 432-37.
[18] Saxena, R., et al. "Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels." Science, vol. 316, no. 5829, 2007, pp. 1331-36.
[19] O'Donnell, Christopher J., et al. "Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study." BMC Med Genet, vol. 8, suppl. 1, 2007.